Effects of Short-term High Dose Atorvastatin on Left Ventricular Remodeling in Patients with First Time Attack of Anterior Acute Myocardial Infarction |
| |
Authors: | Zhijian Liu Gaopin Hu Meiying Fei Zao Yin Quanxing Shi Fei Sun |
| |
Affiliation: | 1 Department of Cardiology, the 210th Hospital of People’s Liberation Army, Dalian, Liaoning 116021, China;2 Department of Cardiology, the 306th Hospital of People’s Liberation Army, Beijing 100101, China; |
| |
Abstract: | Objects The aim of this trial was to evaluate the effect of short-term high-dose atorvastatin therapy on levels of high-sensitivity C-reactive protein (hs-CRP), malonaldehyde (MDA), endothelin-1(ET-1), matrix metalloproteinases (MMPs), and left ventricular (LV) remodeling in patients with first time attack of acute anterior myocardial infarction (AAMI) . Methods A hundred and three patients with first time attack of AAMI who underwent successful primary percutaneous coronary intervention were randomized to receive atorvastatin 40 mg once daily for 1 week followed by 20 mg once daily (intensive treatment group, IT group, n=49), or atorvastatin 20 mg once daily (standard treatment group, ST group, n=54). Plasma levels of hs-CRP, MDA, ET-1, MMP-2 and MMP-9 were measured on admission, at 1 week, 2 weeks and 6 months follow up and compared between the IT group and ST group. Echocardiography was performed on admission, at 2 week, and 1 year follow up. The left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV) and left ventricular ejection fraction (LVEF) were measured at each echocardiographic examination and compared between the IT group and ST group. Results Plasma levels of hs-CRP (F=7.718, P=0.009), ET-1 (F=7.882, P=0.006), MMP-9 (F=4.834, P=0.028) and pro-BNP (F=4.603, P=0.032) were significantly lower at 1 week after initial onset of AAMI in the IT group compared with the ST group. The changes of LVEDV, LVESV, and LVEF at the 1 year follow-up from the admission did not differ between the IT group and the ST group (t=0.722, P=0.444; t=1.228, P=0.221;t=1.354,P=0.187, repectively). Conclusions Short-term high-dose atorvastatin treatment for AAMI was associated with lower hs-CRP, ET-1 and MMP-9 levels compared to the standard dose treatment. However, this beneficial effect is not likely to related to the left ventricular remodeling. |
| |
Keywords: | atorvastatin acute myocardial infarction high-sensitivity C-reactive protein Matrix metalloproteinases left ventricular remodeling |
本文献已被 万方数据 ScienceDirect 等数据库收录! |
| 点击此处可从《中国医学科学杂志(英文版)》浏览原始摘要信息 |
|
点击此处可从《中国医学科学杂志(英文版)》下载全文 |
|